Thomas John Freeburg serves as Executive at Interpace Diagnostics Group, Inc., where they oversee executive responsibilities. Since joining the company, Thomas John Freeburg has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 10, 2021 involved receiving (via award) 50,000 shares valued at $0.
Thomas John Freeburg currently holds 52,000 shares of Interpace Diagnostics Group, Inc. (IDGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas John Freeburg has been a net neutral trader of IDGX stock. They have purchased $0 and sold $0 worth of shares.
Thomas John Freeburg's most recent insider trade was on Mar 10, 2021, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |